Literature DB >> 16780100

[A case of bronchiolitis obliterans syndrome successfully treated by Tiotropium bromide].

Wataru Matsuyama1, Masuki Yamamoto, Kentarou Machida, Ken-Ichi Oonakahara, Masaki Watanabe, Ikkou Higashimoto, Mitsuhiro Osame, Kimiyoshi Arimura.   

Abstract

A 48-year-old woman was admitted with dyspnea on effort. She suffered from adult T-cell leukemia and received peripheral blood stem cell transplantation (PBSCT). Eight months after the PBSCT, she developed dyspnea on effort and was treated with bronchodilator, inhaled corticosteroid, anti-leukotriene drug, theophylline and oxytropium bromide. However her symptoms progressed and she was admitted. We diagnosed bronchiolitis obliterans syndrome (BOS) because of obstructive pulmonary dysfunction, diffuse patchy high density of the lung field on chest computed tomography and decreased ventilation with peripheral patchy accumulation on ventilation scintigraphy. She was treated with corticosteroid and cyclosporine A and her symptoms and her pulmonary function were improved. However, in parallel with corticosteroid tapering, her symptoms and pulmonary functions worsened. Treatment with Tiotropium bromide was started and her pulmonary function improved significantly. Her pulmonary function did not worsen and tapering steroid dose was successfully achieved. PBSCT was reported to up-regulate the muscarinic receptor activity in lung. Tiotropium bromide might become one additional option for the treatment of BOS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16780100

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  1 in total

1.  Tiotropium use and pulmonary function in patients with constrictive bronchiolitis.

Authors:  Alexandre Melo Kawassaki; Letícia Kawano-Dourado; Ronaldo Adib Kairalla
Journal:  J Bras Pneumol       Date:  2014 Jan-Feb       Impact factor: 2.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.